Published in JAMA on February 09, 2000
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab (2006) 1.63
Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab (2010) 1.62
Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci (2011) 1.43
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev (2013) 1.33
Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle. Mol Cell Endocrinol (2012) 1.12
A systematic review of the effects of different types of therapeutic exercise on physiologic and functional measurements in patients with HIV/AIDS. Clinics (Sao Paulo) (2013) 1.11
Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals. Fertil Steril (2011) 1.08
Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): design and methods. Contemp Clin Trials (2008) 1.06
Sarcopenia during androgen-deprivation therapy for prostate cancer. J Clin Oncol (2012) 1.03
Myocytic androgen receptor controls the strength but not the mass of limb muscles. Proc Natl Acad Sci U S A (2010) 0.98
Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting. Am J Clin Nutr (2010) 0.97
The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab (2010) 0.96
Impact of Aerobic and Resistance Exercise on the Health of HIV-Infected Persons. Am J Lifestyle Med (2009) 0.96
Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury. J Appl Physiol (1985) (2009) 0.93
Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels. J Clin Endocrinol Metab (2013) 0.92
Effect of progressive resistance exercise on strength evolution of elderly patients living with HIV compared to healthy controls. Clinics (Sao Paulo) (2011) 0.91
Treatment of Men for "Low Testosterone": A Systematic Review. PLoS One (2016) 0.90
Testosterone correlates with Venezuelan equine encephalitis virus infection in macaques. Virol J (2006) 0.90
Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism. J Physiol (2011) 0.89
Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies. Curr Opin Clin Nutr Metab Care (2010) 0.89
Identification of serum biomarkers for aging and anabolic response. Immun Ageing (2011) 0.86
Nutritional interventions for cancer-induced cachexia. Curr Probl Cancer (2011) 0.85
Moderate-Intensity Exercise Improves Body Composition and Improves Physiological Markers of Stress in HIV-Infected Men. ISRN AIDS (2012) 0.84
Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial. Support Care Cancer (2013) 0.83
Testosterone enables growth and hypertrophy in fusion impaired myoblasts that display myotube atrophy: deciphering the role of androgen and IGF-I receptors. Biogerontology (2015) 0.83
An Increased Risk of Osteoporosis during Acquired Immunodeficiency Syndrome. Int J Med Sci (2004) 0.82
Relation between sex hormone concentrations, peripheral arterial disease, and change in ankle-brachial index: findings from the Framingham Heart Study. J Clin Endocrinol Metab (2011) 0.82
Hypogonadism in human immunodeficiency virus-positive men. Korean J Urol (2014) 0.81
A pilot trial of a videogame-based exercise program for methadone maintained patients. J Subst Abuse Treat (2014) 0.80
Optimizing the benefits of exercise on physical function in older adults. PM R (2013) 0.78
A Systematic Review of the Effects of Exercise Interventions on Body Composition in HIV+ Adults. Open AIDS J (2015) 0.78
The use of anabolic steroids as a strategy in reversing denervation atrophy after delayed nerve repair. Hand (N Y) (2011) 0.77
Nonprescription steroids on the Internet. Subst Use Misuse (2011) 0.77
Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy. BMC Infect Dis (2016) 0.75
Effects of eight weeks of an alleged aromatase inhibiting nutritional supplement 6-OXO (androst-4-ene-3,6,17-trione) on serum hormone profiles and clinical safety markers in resistance-trained, eugonadal males. J Int Soc Sports Nutr (2007) 0.75
Hypogonadism in the HIV-Infected Man. Curr Treat Options Infect Dis (2017) 0.75
Exercise regimens for men with HIV. JAMA (2000) 0.75
Effectiveness of Progressive Resistive Exercise (PRE) in the context of HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol. BMC Infect Dis (2017) 0.75
Effects of a 2-Year Supervised Exercise Program Upon the Body Composition and Muscular Performance of HIV-Infected Patients. Open AIDS J (2015) 0.75
Crystallization and preliminary X-ray analysis of the human androgen receptor ligand-binding domain with a coactivator-like peptide and selective androgen receptor modulators. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.75
HIV Wasting Syndrome in a Nigerian Failing Antiretroviral Therapy: A Case Report and Review of the Literature. Case Rep Med (2010) 0.75
Effects of Strength Training and Anabolic Steroid in the Peripheral Nerve and Skeletal Muscle Morphology of Aged Rats. Front Aging Neurosci (2017) 0.75
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med (1996) 4.10
Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med (1994) 3.25
Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr (1989) 2.75
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA (1999) 2.56
Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab (1996) 2.30
Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med (1992) 2.03
Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol (1989) 1.98
Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab (1997) 1.73
The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab (1998) 1.71
Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab (1996) 1.70
Endocrine function in the HIV wasting syndrome. J Acquir Immune Defic Syndr (1994) 1.58
Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med (1996) 1.34
Endocrine disorders in men infected with human immunodeficiency virus. Am J Med (1988) 1.32
Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev (1996) 1.17
Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1996) 1.16
Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab (1996) 1.15
The effect of exercise training on aerobic fitness, immune indices, and quality of life in HIV+ patients. Med Sci Sports Exerc (1998) 1.12
Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus. AIDS (1999) 1.04
Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons. Med Sci Sports Exerc (1993) 1.03
Endocrine function in 98 HIV-infected patients: a prospective study. AIDS (1991) 1.02
Serum hormones in men with human immunodeficiency virus-associated wasting. J Clin Endocrinol Metab (1996) 1.02
Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 1.00
Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab (1998) 0.98
Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. J Clin Psychopharmacol (1999) 0.95
Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men. J Clin Endocrinol Metab (1989) 0.94
Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus. J Clin Endocrinol Metab (1999) 0.90
Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss. J Androl (1999) 0.85
Evaluation of nuclear magnetic resonance spectroscopy for determination of deuterium abundance in body fluids: application to measurement of total-body water in human infants. Am J Clin Nutr (1987) 0.84
Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection. Br J Nutr (1996) 0.84
A trial of testosterone therapy for HIV-associated weight loss. AIDS (1997) 0.83
Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection. AIDS (1996) 0.83
Testicular atrophy in homosexual AIDS patients: an immune-mediated phenomenon? Hum Pathol (1989) 0.83
The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection. Am J Med (1999) 0.83
Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.81
Effect of anabolic steroids on HIV-related wasting myopathy. South Med J (1993) 0.80
The MOS short-form general health survey. Reliability and validity in a patient population. Med Care (1988) 21.00
Further Studies on Bacterial Nutrition: The Utilization of Proteid and Non-Proteid Nitrogen. J Bacteriol (1916) 12.86
The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA (1989) 12.07
Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA (1989) 11.97
Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol (2001) 10.35
A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med (2001) 9.98
Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10
Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol (1998) 5.64
Are Latinos less satisfied with communication by health care providers? J Gen Intern Med (1999) 5.26
Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol (1993) 5.13
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. N Engl J Med (1992) 4.71
Quality-of-life outcomes in men treated for localized prostate cancer. JAMA (1995) 4.69
Methods for measuring patient satisfaction with specific medical encounters. Med Care (1988) 4.38
The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care (1998) 4.34
Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med (2001) 4.28
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med (1996) 4.10
Differences in CAHPS adult survey reports and ratings by race and ethnicity: an analysis of the National CAHPS benchmarking data 1.0. Health Serv Res (2001) 3.62
Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry (1992) 3.48
A health-related quality of life measure for multiple sclerosis. Qual Life Res (1995) 3.46
A comparative review of generic quality-of-life instruments. Pharmacoeconomics (2000) 3.42
Applications of retrovirus-mediated expression cloning. Exp Hematol (1996) 3.40
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS (2000) 3.39
Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med (1992) 3.38
Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J (1997) 3.27
The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology (2000) 3.25
Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial. JAMA (2000) 3.13
Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor. Infect Immun (1970) 3.01
The limitation of referral level fetal ultrasound examination in the detection of spina bifida in Western Australia, 1990-1991. Med J Aust (1993) 3.00
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA (1997) 2.80
Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study. JAMA (1989) 2.79
Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab (2001) 2.79
Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res (1997) 2.75
Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA. Learn Mem (1999) 2.72
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab (2000) 2.68
Racial and ethnic differences in parents' assessments of pediatric care in Medicaid managed care. Health Serv Res (2001) 2.68
Managed care and capitation in California: how do physicians at financial risk control their own utilization? Ann Intern Med (1995) 2.64
FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet (1998) 2.56
Self-study from web-based and printed guideline materials. A randomized, controlled trial among resident physicians. Ann Intern Med (2000) 2.40
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA (1999) 2.36
The DIURNAL project: DIURNAL and circadian expression profiling, model-based pattern matching, and promoter analysis. Cold Spring Harb Symp Quant Biol (2007) 2.35
A randomized trial of the use of patient self-assessment data to improve community practices. Eff Clin Pract (1999) 2.24
Overlapping functions of the yeast oxysterol-binding protein homologues. Genetics (2001) 2.16
Value of functional status as a predictor of mortality: results of a prospective study. Am J Med (1992) 2.15
Comparison of community based service with hospital based service for people with acute, severe psychiatric illness. BMJ (1993) 2.14
Work characteristics and pesticide exposures among migrant agricultural families: a community-based research approach. Environ Health Perspect (2001) 2.14
Acid- and base-induced proteins during aerobic and anaerobic growth of Escherichia coli revealed by two-dimensional gel electrophoresis. J Bacteriol (1999) 2.14
Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A (1998) 2.13
Case-mix adjustment of the National CAHPS benchmarking data 1.0: a violation of model assumptions? Health Serv Res (2001) 2.10
Emerging patterns of HIV transmission: the value of alternative surveillance methods. AIDS (1995) 2.09
Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med (1993) 2.03
Do consumer reports of health plan quality affect health plan selection? Health Serv Res (2000) 2.03
The functional status of patients. How can it be measured in physicians' offices? Med Care (1990) 2.03
High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr (2000) 2.00
Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab (2000) 1.99
Confirmatory factor analysis of the Consumer Assessment of Health Plans Study (CAHPS) 1.0 Core Survey. Psychol Assess (2001) 1.96
Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J Exp Med (1993) 1.95
4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors. J Med Chem (2000) 1.94
Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc Natl Acad Sci U S A (2001) 1.94
Development of the quality of life in epilepsy inventory. Epilepsia (1995) 1.93
Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry (2000) 1.90
A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care (1992) 1.84
Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J (2001) 1.83
The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol (1995) 1.82
Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann Neurol (1995) 1.82
Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J Virol (1998) 1.80
Bovine spongiform encephalopathy. Br Med J (Clin Res Ed) (1988) 1.80
Resistant starch lowers fecal concentrations of ammonia and phenols in humans. Am J Clin Nutr (1996) 1.78
A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development. Mol Cell Biol (1997) 1.77
Intestinal macrophages and response to microbial encroachment. Mucosal Immunol (2010) 1.76
Resistance exercise acutely increases MHC and mixed muscle protein synthesis rates in 78-84 and 23-32 yr olds. Am J Physiol Endocrinol Metab (2000) 1.75
Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1999) 1.74
Sedation and analgesia for colonoscopy: patient tolerance, pain, and cardiorespiratory parameters. Gastrointest Endosc (1997) 1.74
Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab (1997) 1.73
Cerebral abnormalities in myotonic dystrophy. Cerebral blood flow, magnetic resonance imaging, and neuropsychological tests. Arch Neurol (1993) 1.73
The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab (1998) 1.71
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Primary care physicians' satisfaction with quality of care in California capitated medical groups. JAMA (1997) 1.68
Receptive-field organization of monkey superior colliculus. J Neurophysiol (1972) 1.68
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. Allergy (2008) 1.66
Evaluating the equivalence of health care ratings by whites and Hispanics. Med Care (2000) 1.65
Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study. Qual Life Res (2000) 1.63
Comparison of pediatric resident and faculty learning styles: implications for medical education. Am J Med Sci (1996) 1.62
Stepping through the drug use sequence: longitudinal scalogram analysis of initiation and regular use. J Abnorm Psychol (1992) 1.62
Acute cholecystitis--room for improvement? Ann R Coll Surg Engl (2002) 1.61
Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann Intern Med (2001) 1.57
Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab (1996) 1.57